CNS & Neurological Disorders - Drug Targets
Title:Meet Our Editorial Board Member
Volume: 15 Issue: 9
Author(s): Prabhakara V. Choudary
Affiliation:
Export Options
About this article
Cite this article as:
Choudary V. Prabhakara, Meet Our Editorial Board Member, CNS & Neurological Disorders - Drug Targets 2016; 15 (9) . https://dx.doi.org/10.2174/187152731509161007120852
DOI https://dx.doi.org/10.2174/187152731509161007120852 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
21
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Imidazole Incorporated Semicarbazone Derivatives as a New Class of Anticonvulsants: Design, Synthesis and In-Vivo Screening
Medicinal Chemistry KIR Molecules: Recent Patents of Interest for the Diagnosis and Treatment of Several Autoimmune Diseases, Chronic Inflammation, and B-cell Malignancies
Recent Patents on DNA & Gene Sequences Peptide Arrays for the Analysis of Antibody Epitope Recognition Patterns
Mini-Reviews in Organic Chemistry Can Life Before Birth Affect Health Ever After?
Current Women`s Health Reviews Follow the ATP: Tumor Energy Production: A Perspective
Anti-Cancer Agents in Medicinal Chemistry Electroacupuncture Ameliorates CUMS-induced Depression-like Behavior: Involvement of the Glutamatergic System and Apoptosis in Rats
Combinatorial Chemistry & High Throughput Screening Meet Our Associate Editor
Current Drug Delivery Cholinesterase Inhibitors and Beyond
Current Alzheimer Research The Application of Rational Design on Phospholipase A2 Inhibitors
Current Medicinal Chemistry Therapeutic Utility of NK3 Receptor Antagonists for the Treatment of Schizophrenia
Current Pharmaceutical Design Whole Brain Atrophy and Sample Size Estimate via Iterative Principal Component Analysis for Twelve-month Alzheimer's Disease Trials
Neuroscience and Biomedical Engineering (Discontinued) Chromatin Remodeling Agents for Cancer Therapy
Reviews on Recent Clinical Trials Patent Selections:
Recent Patents on CNS Drug Discovery (Discontinued) An Integrated and Disease-Oriented Growth Factor-Regulated Signal Transduction Network
Current Molecular Medicine Neuroendocrine Stimulation of Mucosal Immune Cells in Inflammatory Bowel Disease
Current Pharmaceutical Design ROS Acts as a Double-Edged Sword in the Pathogenesis of Type 2 Diabetes Mellitus: Is Nrf2 a Potential Target for the Treatment?
Mini-Reviews in Medicinal Chemistry The CRF Receptor Structure, Function and Potential for Therapeutic Intervention.
Current Medicinal Chemistry - Central Nervous System Agents Nasal Drug Delivery System-Factors Affecting and Applications
Current Drug Therapy T9-T10 Osteomyelitis, Epidural Abscess and Cord Compression Secondary to <i>Mycobacterium abscessus</i>: A Case Report
Infectious Disorders - Drug Targets The Role and Therapeutic Potential of Ser/Thr Phosphatase PP2A in Apoptotic Signalling Networks in Human Cancer Cells
Current Molecular Medicine